Verily Life Sciences opens R&D center in Israel

Last month, Verily Life Sciences, an Alphabet company based in California, focusing on data science, healthcare and technology, announced the opening of its new research and development center in Israel. The company will work with Israeli hospitals and healthcare organisations to apply artificial intelligence (AI) techniques to biomedical challenges, such as the application of minimally invasive surgery and endoscopy. One of the center’s objectives is to advance early research by Google Health and Shaare Zedek Medical Center in Jerusalem to examine the application of AI in detecting colon cancer.

This collaboration illustrates the growing trend of using artificial intelligence in the healthcare and biomedicine sector to treat pressing health conditions. Google already has a presence in Israel and the introduction of this new center comes after a successful collaboration between Google Health and Shaare Zedek Medical Center in the field of colonoscopy.

Establishing a research center in Israel, often referred to as the Start-up Nation, will enable Verily to benefit from the dynamic health ecosystem in Israel and accelerate its research and development efforts. Professor Eran Goldin, the Director of the Digestive Diseases Institute at Shaare Zedek, commended the collaboration with Verily, noting that it has led to the introduction of a precise model that facilitates the diagnosis and treatment of colon cancer through AI.

The Verily Israel Team will be co-located with Google in Haifa and Tel Aviv, where it will recruit scientists, engineers and researchers to innovate in the field of AI and healthcare. This partnership is expected to have significant growth potential for the medical community at large and for the advancement of innovative technology to enhance medical treatment.